In vitro bioassay for human serum follicle-stimulating hormone (FSH) based on L cells transfected with recombinant rat FSH receptor: validation of a model system.

Endocrinology ◽  
1994 ◽  
Vol 135 (5) ◽  
pp. 2204-2213 ◽  
Author(s):  
T Gudermann ◽  
H Brockmann ◽  
M Simoni ◽  
J Gromoll ◽  
E Nieschlag
2010 ◽  
Vol 31 (1) ◽  
pp. 133-134 ◽  
Author(s):  
Tsilya Gerasimova ◽  
Maria N. Thanasoula ◽  
Dimitrios Zattas ◽  
Emre Seli ◽  
Denny Sakkas ◽  
...  

2019 ◽  
Vol 101 (4) ◽  
pp. 719-732 ◽  
Author(s):  
Anna Tetkova ◽  
Andrej Susor ◽  
Michal Kubelka ◽  
Lucie Nemcova ◽  
Denisa Jansova ◽  
...  

Abstract Culture media used in assisted reproduction are commonly supplemented with gonadotropin hormones to support the nuclear and cytoplasmic maturation of in vitro matured oocytes. However, the effect of gonadotropins on protein synthesis in oocytes is yet to be fully understood. As published data have previously documented a positive in vitro effect of follicle-stimulating hormone (FSH) on cytoplasmic maturation, we exposed mouse denuded oocytes to FSH in order to evaluate the changes in global protein synthesis. We found that dose-dependent administration of FSH resulted in a decrease of methionine incorporation into de novo synthesized proteins in denuded mouse oocytes and oocytes cultured in cumulus-oocyte complexes. Similarly, FSH influenced methionine incorporation in additional mammalian species including human. Furthermore, we showed the expression of FSH-receptor protein in oocytes. We found that major translational regulators were not affected by FSH treatment; however, the amino acid uptake became impaired. We propose that the effect of FSH treatment on amino acid uptake is influenced by FSH receptor with the effect on oocyte metabolism and physiology.


2010 ◽  
Vol 24 (1) ◽  
pp. 275-276
Author(s):  
Tsilya Gerasimova ◽  
Maria N. Thanasoula ◽  
Dimitrios Zattas ◽  
Emre Seli ◽  
Denny Sakkas ◽  
...  

ABSTRACT Context Follicle stimulating hormone (FSH) mediates cyclic follicle growth and development and is widely used for controlled ovarian stimulation in women undergoing infertility treatment. The ovarian response of women to FSH is variable, ranging from poor response to ovarian hyperstimulation. Objective We investigated whether genetic alterations of the FSH receptor (FSHR) contribute to this variability. Design and Patients Our approach was to study women undergoing treatment with In Vitro Fertilization (IVF) falling into the edges of the normal distribution of ovarian response to FSH, with respect to age. Setting Yale Fertility Clinic. Methods We extracted RNA from cumulus cells surrounding the oocytes of women undergoing IVF and analyzed the FSHR mRNA by RT-PCR and sequencing. Results We identified four abnormal FSHR splicing products (3 exon deletions and 1 intron insertion) in the FSHR mRNA in 37% (13/35) of women tested. All alterations affected the extracellular ligand-binding portion of the receptor without causing a frameshift. When transfected in HEK293T cells, all four splicing variants showed markedly decreased cAMP activation compared to controls. Untransfected cells showed no response to FSH, while all the cell lines showed normal cAMP activation when treated with Forskolin, a non-receptor mediated cAMP stimulant. None of the normal or mutant forms showed any response to luteinizing or thyroid stimulating hormones. Conclusions Our findings strongly indicate FSHR variants as being an intrinsic genetic cause of some forms of infertility and identify a need for functional characterization of these variants and the investigation of more individualized ovarian stimulation protocols.


Sign in / Sign up

Export Citation Format

Share Document